Delivery Order SPE2DB20D2104-SPE2DB20FR33Z
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,854.80 delivery order contract is for the Prime Vendor Pharmaceutical Branch in Philadelphia, with a completion date of September 2, 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,513.04 delivery order contract is a firm fixed-price agreement for the Prime Vendor Pharmaceutical Branch in Philadelphia, with a period of performance through May 18, 2021. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,712.34 firm fixed-price delivery order is for a Prime Vendor Pharmacy Branch in Philadelphia, with a completion date of June 19, 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $8,642.21 firm fixed-price delivery order is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with a completion date of September 16, 2020. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,374.53, is a delivery order for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" and has a completion date of February 24, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,124.91 firm-fixed-price delivery order is for a Prime Vendor Pharmacy Branch in Philadelphia, Pennsylvania, with an ultimate completion date of October 27, 2020. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for a Prime Vendor Pharmaceutical Branch-Philadelphia delivery order valued at $4,632.00, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a performance period through May 20, 2021 and is a firm fixed price delivery order. Amerisourcebergen, through its parent company Cencora, Inc., holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,728.04 firm fixed-price delivery order is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with a period of performance through July 15, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant...
- This federal contract award is for a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,730.84 firm fixed-price contract is for a prime vendor pharmacy program serving the DLA's Philadelphia branch, with an ultimate completion date of August 19, 2020. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,967.64 delivery order is for a "Prime Vendor Pharm Branch-Philadelphia" and has an ultimate completion date of September 4, 2020. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., also known as Amerisourcebergen. The company holds a significant $999,999,999 Indefinite...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB20FR33ZDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,758.64 firm fixed-price delivery order is for a Prime Vendor Pharmacy Branch in Philadelphia, with a completion date of September 2, 2020. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical healthcare commodities to support military and veteran healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 9/1/20 |